BRPI0919183B8 - composição comprimível de eritritol, processo e uso do mesmo - Google Patents

composição comprimível de eritritol, processo e uso do mesmo

Info

Publication number
BRPI0919183B8
BRPI0919183B8 BRPI0919183A BRPI0919183A BRPI0919183B8 BR PI0919183 B8 BRPI0919183 B8 BR PI0919183B8 BR PI0919183 A BRPI0919183 A BR PI0919183A BR PI0919183 A BRPI0919183 A BR PI0919183A BR PI0919183 B8 BRPI0919183 B8 BR PI0919183B8
Authority
BR
Brazil
Prior art keywords
erythritol
compressible composition
cellulose
isomalt
maltitol
Prior art date
Application number
BRPI0919183A
Other languages
English (en)
Inventor
Patricia L Boghmans Catherine
Maria Fernande Meeus Liesbeth
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of BRPI0919183A2 publication Critical patent/BRPI0919183A2/pt
Publication of BRPI0919183B1 publication Critical patent/BRPI0919183B1/pt
Publication of BRPI0919183B8 publication Critical patent/BRPI0919183B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/34—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05F—ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
    • C05F11/00—Other organic fertilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/20—Organic compounds containing oxygen
    • C11D3/2003—Alcohols; Phenols
    • C11D3/2065—Polyhydric alcohols

Abstract

produção de comprimidos de eritritol. a presente invenção refere-se ao eritritol que possui uma área de superfície específica maior que 0,25 m2/g, preferencialmente maior que 0,3 m2/g, e é granulado junto com um selecionado do grupo que consiste em amido pré-gelatinizado, celulose microcristalina, carboximetil celulose, maltose, sorbitol, maltitol, xilitol, isomalte e misturas dos mesmos. os comprimidos são preparados e o processo correspondente é descrito.
BRPI0919183A 2008-09-04 2009-07-28 composição comprimível de eritritol, processo e uso do mesmo BRPI0919183B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08015598 2008-09-04
PCT/EP2009/005460 WO2010025796A1 (en) 2008-09-04 2009-07-28 Tabletting of ervthritol

Publications (3)

Publication Number Publication Date
BRPI0919183A2 BRPI0919183A2 (pt) 2015-08-18
BRPI0919183B1 BRPI0919183B1 (pt) 2020-05-05
BRPI0919183B8 true BRPI0919183B8 (pt) 2021-05-25

Family

ID=39870661

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919183A BRPI0919183B8 (pt) 2008-09-04 2009-07-28 composição comprimível de eritritol, processo e uso do mesmo

Country Status (16)

Country Link
US (2) US20110250247A1 (pt)
EP (1) EP2334202B1 (pt)
JP (1) JP5718231B2 (pt)
KR (1) KR101651702B1 (pt)
CN (1) CN102143692A (pt)
AT (1) ATE543393T1 (pt)
BR (1) BRPI0919183B8 (pt)
CA (1) CA2735037C (pt)
DK (1) DK2334202T3 (pt)
ES (1) ES2377869T3 (pt)
HR (1) HRP20120121T1 (pt)
PL (1) PL2334202T3 (pt)
PT (1) PT2334202E (pt)
RU (1) RU2498636C2 (pt)
SI (1) SI2334202T1 (pt)
WO (1) WO2010025796A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102905691A (zh) * 2010-06-01 2013-01-30 卡吉尔公司 赤藓糖醇和异麦芽酮糖醇的口腔分散片剂
CN104244738A (zh) * 2012-04-20 2014-12-24 帝斯曼知识产权资产管理有限公司 固体的颜色稳定的l-抗坏血酸组合物
FR3023128B1 (fr) * 2014-07-01 2017-11-10 Roquette Freres Nouvelle composition edulcorante
WO2018003762A1 (ja) * 2016-06-28 2018-01-04 株式会社日本抗菌総合研究所 賦形剤及び錠剤
US11351103B2 (en) * 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
JP6840849B2 (ja) * 2016-11-18 2021-03-10 フェルティン ファルマ アー／エス 別個の結合剤及びエリスリトールを含む錠剤
FR3068249B1 (fr) * 2017-06-30 2019-08-16 L'oreal Composition cosmetique solide nettoyante
MY172113A (en) * 2017-07-05 2019-11-14 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
CN109418809A (zh) * 2017-08-26 2019-03-05 石家庄以岭药业股份有限公司 一种西梅咀嚼片及其制备方法
MY186286A (en) * 2017-09-05 2021-07-05 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11135157B2 (en) * 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
CN111035620B (zh) * 2019-12-25 2021-08-27 广州莱可福生物科技有限公司 一种辅料组合物、植物甾醇复合营养素咀嚼片及其制备方法
CN111548218A (zh) * 2020-04-27 2020-08-18 上海应用技术大学 一种通用型花肥速释片及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100009D0 (en) * 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
CN1222317C (zh) * 1996-07-12 2005-10-12 第一制药株式会社 可迅速崩解的压模物质及其生产方法
JP2003176242A (ja) * 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
JP4358919B2 (ja) * 1998-10-07 2009-11-04 興和創薬株式会社 口腔内速溶性固形物の製造方法
JP4358920B2 (ja) * 1998-10-07 2009-11-04 興和創薬株式会社 エリスリトール含有球形顆粒剤及びその製造方法
US20040121006A1 (en) * 2001-03-06 2004-06-24 Shoichi Narita Utilization of spray-dried powder containing sugar alcohol
NZ586280A (en) * 2003-04-08 2011-12-22 Novartis Ag Oral pharmaceutical composition comprising FTY720 and mannitol
US8153157B2 (en) * 2005-04-22 2012-04-10 Asahi Kasei Chemicals Corporation Porous cellulose aggregate and molding composition thereof
JP4955974B2 (ja) * 2005-09-30 2012-06-20 小林製薬株式会社 錠菓
FR2904224B1 (fr) * 2006-07-28 2008-10-10 Roquette Freres Sorbitol granule et son procede de preparation
EP2264042B1 (en) * 2007-07-27 2012-07-18 Cargill, Incorporated Micronization of polyols

Also Published As

Publication number Publication date
EP2334202A1 (en) 2011-06-22
BRPI0919183B1 (pt) 2020-05-05
ES2377869T3 (es) 2012-04-02
PT2334202E (pt) 2012-02-28
HRP20120121T1 (hr) 2012-03-31
WO2010025796A1 (en) 2010-03-11
PL2334202T3 (pl) 2012-04-30
CA2735037A1 (en) 2010-03-11
KR20110085976A (ko) 2011-07-27
SI2334202T1 (sl) 2012-04-30
BRPI0919183A2 (pt) 2015-08-18
JP2012501630A (ja) 2012-01-26
DK2334202T3 (da) 2012-03-05
CA2735037C (en) 2016-07-12
KR101651702B1 (ko) 2016-08-26
RU2498636C2 (ru) 2013-11-20
RU2011112805A (ru) 2012-10-10
EP2334202B1 (en) 2012-02-01
US20110250247A1 (en) 2011-10-13
JP5718231B2 (ja) 2015-05-13
ATE543393T1 (de) 2012-02-15
US20150320034A1 (en) 2015-11-12
CN102143692A (zh) 2011-08-03

Similar Documents

Publication Publication Date Title
BRPI0919183B8 (pt) composição comprimível de eritritol, processo e uso do mesmo
LTPA2017024I1 (lt) Priešvėžinis vaistas, turintis alfa, alfa, alfa-trifluortimidino ir timidinfosforilazės inhibitorių
JP2010507682A5 (pt)
NO20082793L (no) Nye tiofenderivater
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
MY146574A (en) Stabilized pharmaceutical compositions comprising fesoterodine
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
CL2007003797A1 (es) Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades.
CL2008001465A1 (es) Compuestos derivados de [2,1,3]benzoxadiazol-5-carboxamidas, moduladores de los receptores ampa; composiciones farmacéuticas; y su uso en el tratamiento de afecciones hipoglutamatérgicas, trastornos cognitivos, enfermedad de parkinson, adhd, síndrome de rett, depresión respiratoria, síndrome x frágil y enfermedad de alzheimer.
DK2024352T3 (da) Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling
CL2007003819A1 (es) Compuestos derivados de isoquinolina e isoquinolinona; composicion farmaceutica; y su uso para tratar y/o prevenir hipertension, retinopatia, glaucoma, fibrosis pulmonar, alzheimer, entre otras enfermedades.
EP2030974A4 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
WO2009022233A3 (en) Oral tobacco product having a hydrated membrane coating and a high surface area
CL2007003636A1 (es) Compuestos derivados de benzoimidazol sustituidos con sulfonilfenil; proceso para preparar dichos compuestos; composicion farmaceutica que comprenden dichos compuestos; y su uso para tratar el dolor cronico o agudo, debido a una enfermedad que causa
CL2008000440A1 (es) Compuestos derivados de 4-aril-3-piridazina, antagonistas del receptor de dopamina 2 de rapida disociacion; composicion farmaceutica que comprende a dichos compuestos; y su uso como antipsicotico para el tratamiento o prevencion de la esquizofrenia,
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
JP2008519810A5 (pt)
CL2007002315A1 (es) Compuestos derivados de piridina;composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades o trastornos que comprenden el dolor y/o sindrome del intestino irritable.
CL2007003110A1 (es) Compuestos derivados de ciclohexilamida, moduladores de los receptores de serotonina 5-ht2a y dopamina d3; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos cognitivos, adiccion a las drogas, depresi
IL204751A0 (en) Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
ITRM20050074A1 (it) Miscela da utilizzare per la produzione di trasferibili per decalcomania, prodotto trasferibile per decalcomania e relativo procedimento di produzione, e procedimento di decalcomania utilizzante tale prodotto trasferibile.
EA200700207A1 (ru) Твёрдая фармацевтическая композиция, включающая миртазапин
UA94107C2 (ru) Стабилизированная фармацевтическая композиция фезотеродина
UA38262U (uk) Лікарський препарат у формі таблеток на основі міансерину гідрохлориду

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Ipc: A01N 25/08 (2006.01), A23L 27/30 (2016.01), A23P 1

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/07/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF